Article Citation
Baradari V, Höpfner M, Huether A, Schuppan D, Scherübl H. Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells. World J Gastroenterol 2007; 13(33): 4458-4466 [PMID: 17724801 DOI: 10.3748/wjg.v13.i33.4458]
Please LOGIN to submit a new comment.